BMI1 and ovarian carcinoma: That BMI1 is involved in regulating homologous recombination repair43 and is the target of pharmacologic small molecule inhibitors (PTC02829 and PTC59644), we sought to further understand whether this protein represented a hitherto unrecognized player in the ovarian cancer HRP phenotype.